GlobalFoundries Inc. (NASDAQ: GFS) reported an insider sale by Chief Legal Officer Azar Samak L., who sold 500 shares of company stock on March 19, 2026, at $41.59 per share for a total consideration of $20,795.
After completing the transaction, Samak directly holds 19,494 shares of GlobalFoundries. According to InvestingPro data cited with the transaction, the company’s share price has since moved up to $44.39, which the data provider characterizes as a 30% increase over the past six months. The same platform’s Fair Value analysis indicates the stock is trading slightly above its estimated fair value.
The insider sale was carried out under a Rule 10b5-1 trading plan that was put in place prior to the company’s securities offering. The sale also qualifies as a permissible exemption under the terms of a lock-up agreement that expires on May 10, 2026.
Separately, Mubadala Technology Investment Company priced a secondary offering of 20 million ordinary shares at $42.00 per share, generating $840 million in proceeds for the selling shareholder. The offering was reportedly four times oversubscribed, a sign of strong demand from long-term investors. GlobalFoundries itself did not sell any shares in the transaction and will not receive proceeds from the sale. Under the underwriting agreement, the selling shareholder granted underwriters a 30-day option to buy up to an additional 3 million shares.
In a related leadership movement, USA Rare Earth has added Dr. Thomas Caulfield to its Board of Directors. Dr. Caulfield is the Executive Chairman of GlobalFoundries and previously served as the company’s CEO, leading the firm through its 2021 initial public offering.
These items - an insider sale executed under a pre-existing trading plan, a large secondary share sale by a major shareholder, and a board appointment involving GlobalFoundries’ executive chairman - together underline active capital markets and leadership developments connected to the company. The transactions and appointments are discrete events: the insider sale was performed under plan and a lock-up exemption, the Mubadala offering did not involve proceeds for GlobalFoundries, and Dr. Caulfield’s board role is a separate corporate appointment.
Investors seeking additional financial context and valuation details can consult the referenced Pro Research Report for GlobalFoundries and other covered U.S. equities.